Molecules/PATRITUMAB DERUXTECAN

PATRITUMAB DERUXTECAN

Molecular Identity

Antibody drug conjugatePhase 3

Mechanism of action: Receptor tyrosine-protein kinase erbB-3 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

PATRITUMAB DERUXTECANU3 1402U3-1402U31402U3-1402A

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to PATRITUMAB DERUXTECAN

Loading drug network...